Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Apocrine ductal carcinoma in situ of the breast: histologic classification and expression of biologic markers.

Leal C, Henrique R, Monteiro P, Lopes C, Bento MJ, De Sousa CP, Lopes P, Olson S, Silva MD, Page DL.

Hum Pathol. 2001 May;32(5):487-93.

PMID:
11381366
2.
3.

Apoptosis in breast cancer: relationship with other pathological parameters.

Lipponen P.

Endocr Relat Cancer. 1999 Mar;6(1):13-6. Review.

4.

Quantitation and morphometric analysis of tumors by image analysis.

Aziz DC, Barathur RB.

J Cell Biochem Suppl. 1994;19:120-5. Review.

PMID:
7823583
5.

Evaluation of biomarkers in breast and prostate cancer.

Grizzle WE, Myers RB, Arnold MM, Srivastava S.

J Cell Biochem Suppl. 1994;19:259-66. Review.

PMID:
7823598
7.

c-erbB-2 amplification in mammary carcinoma.

Barnes DM.

J Cell Biochem Suppl. 1993;17G:132-8. Review.

PMID:
7911860
8.

Role of the pathologist in biomarker studies.

Wilkinson EJ, Hendricks JB.

J Cell Biochem Suppl. 1995;23:10-8. Review.

PMID:
8747373
9.

Alteration of immunohistochemical biomarkers between pre- and post-chemotherapy: hormone receptors, HER2 and Ki-67.

Kumaki N, Umemura S, Tang X, Saito Y, Suzuki Y, Tokuda Y.

Breast Cancer. 2011 Apr;18(2):98-102. doi: 10.1007/s12282-010-0238-1. Epub 2011 Feb 3. Review.

PMID:
21290265
10.
11.

Biological markers of invasive breast cancer.

Matsumoto A, Jinno H, Ando T, Fujii T, Nakamura T, Saito J, Takahashi M, Hayashida T, Kitagawa Y.

Jpn J Clin Oncol. 2016 Feb;46(2):99-105. doi: 10.1093/jjco/hyv153. Epub 2015 Oct 20. Review.

PMID:
26486826
12.

Consensus conference on the classification of ductal carcinoma in situ.

[No authors listed]

Hum Pathol. 1997 Nov;28(11):1221-5. Review. No abstract available.

PMID:
9385925
13.

[Breast carcinoma metastatic to meningioma: review of the literature and description of 2 new cases].

Fornelli A, Bacci A, Collina G, Eusebi V.

Pathologica. 1995 Oct;87(5):506-12. Review. Italian.

PMID:
8868176
14.

Controversies in the treatment of ductal carcinoma in situ.

Hughes KS, Lee AK, Rolfs A.

Surg Clin North Am. 1996 Apr;76(2):243-65. Review.

PMID:
8610262
15.

Objective biologic parameters and their clinical relevance in assessing salivary gland neoplasms.

Pinto AE, Fonseca I, Martins C, Soares J.

Adv Anat Pathol. 2000 Sep;7(5):294-306. Review.

PMID:
10976908
16.

Thyroid transcription factor-1 positive primary breast cancer: a case report with review of the literature.

Klingen TA, Chen Y, Gundersen MD, Aas H, Westre B, Sauer T.

Diagn Pathol. 2010 Jun 17;5:37. doi: 10.1186/1746-1596-5-37. Review.

17.

Metaplastic breast carcinoma: a cytohistologic and clinical study of 10 cases.

Johnson TL, Kini SR.

Diagn Cytopathol. 1996 May;14(3):226-32. Review.

PMID:
8732652
18.
19.

Application of image analysis to the evaluation of cellular prognostic factors in breast carcinoma.

Bacus SS, Ruby SG.

Pathol Annu. 1993;28 Pt 1:179-204. Review. No abstract available.

PMID:
8093211
20.

Association of invasive breast carcinoma and multicentric high grade astrocytoma: a case report with a review.

Pour PH, Forouzandeh M, Beni AN, Beni ZN, Hoseinpour P.

Eur Rev Med Pharmacol Sci. 2011 Mar;15(3):337-44. Review.

PMID:
21528782

Supplemental Content

Support Center